Marshall Wace’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.61M | Buy |
|
|||||
|
2025
Q1 | $1.01M | Sell |
|
|||||
|
2024
Q4 | $44.7M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.52M | Sell |
|
|||||
|
2024
Q1 | $6.91M | Sell |
|
|||||
|
2023
Q4 | $41.6M | Buy |
|
|||||
|
2023
Q3 | $18.4M | Sell |
|
|||||
|
2023
Q2 | $18.7M | Buy |
|
|||||
|
2023
Q1 | $1.46M | Sell |
|
|||||
|
2022
Q4 | $62.1M | Buy |
|
|||||
|
2022
Q3 | $39.1M | Sell |
|
|||||
|
2022
Q2 | $48.8M | Buy |
|
|||||
|
2022
Q1 | $28.2M | Sell |
|
|||||
|
2021
Q4 | $55.6M | Buy |
|
|||||
|
2021
Q3 | $26M | Buy |
|
|||||
|
2021
Q2 | $3.42M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $5.65M | Sell |
|
|||||
|
2020
Q3 | $22.5M | Buy |
|
|||||
|
2020
Q2 | $9.9M | Buy |
|
|||||
|
2020
Q1 | $951K | Sell |
|
|||||
|
2019
Q4 | $23.7M | Buy |
|
|||||
|
2019
Q3 | $1.76M | Sell |
|
|||||
|
2019
Q2 | $24.2M | Buy |
|
|||||
|
2019
Q1 | $42K | Sell |
|
|||||
|
2018
Q4 | $2.69M | Buy |
|
|||||
|
2018
Q3 | $949K | Buy |
|
|||||
|
2018
Q2 | $328K | Sell |
|
|||||
|
2018
Q1 | $666K | Buy |
|
|||||
|
2017
Q4 | $481K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.24M | Sell |
|
|||||
|
2017
Q1 | $1.54M | Sell |
|
|||||
|
2016
Q4 | $35.9M | Buy |
|
|||||
|
2016
Q3 | $12.8M | Buy |
|
|||||
|
2016
Q2 | $6.07M | Buy |
|
|||||
|
2016
Q1 | $595K | Sell |
|
|||||
|
2015
Q4 | $15.9M | Sell |
|
|||||
|
2015
Q3 | $23.8M | Buy |
|
|||||
|
2015
Q2 | $22.4M | Buy |
|
|||||
|
2015
Q1 | $18.9M | Buy |
|
|||||
|
2014
Q4 | $10.5M | Sell |
|
|||||
|
2014
Q3 | $18.3M | Sell |
|
|||||
|
2014
Q2 | $27.6M | Buy |
|
|||||
|
2014
Q1 | $334K | Buy |
|